Platelet-rich plasma: Underlying biology and clinical correlates

Regenerative Medicine

Volumn 8, Issue 5, 2013, Pages 645-658

  Andia, Isabel ^a   Abate, Michele ^b  

^a BIOCRUCES BIZKAIA HEALTH RESEARCH INSTITUTE   (Spain)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

angiogenesis; clinical trial; cytokines; extracellular matrix; growth factors; inflammation; pain; platelet rich plasma

Indexed keywords

ALPHA 2 MACROGLOBULIN; ANGIOPOIETIN; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BLOOD CLOTTING FACTOR 13; CALCIUM CHLORIDE; CALCIUM ION; CXCL4 CHEMOKINE; CXCL7 CHEMOKINE; ENDOSTATIN; EPIDERMAL GROWTH FACTOR; FIBRIN; FIBRINOGEN; FIBRINOGEN RECEPTOR; FIBRONECTIN; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; PLATELET DERIVED GROWTH FACTOR; RANTES; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1; THROMBIN; THROMBOCYTE FACTOR 4; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; AVASCULAR NECROSIS; BLOOD CLOTTING; CELLULAR SECRETION; CLINICAL TRIAL (TOPIC); CORNEA EROSION; CYTOKINE RELEASE; DERMATOLOGICAL PROCEDURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRY EYE; EXTRACELLULAR MATRIX; FIBRIN FORMATION; HEMOSTASIS; HUMAN; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; JAW OSTEONECROSIS; LEG ISCHEMIA; LEG ULCER; LEUKOCYTE MIGRATION; LIGAMENT LESION; NEOVASCULARIZATION (PATHOLOGY); PLASTIC SURGERY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SURGICAL WOUND; TENDON LESION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA; THROMBOCYTE TRANSFUSION; TISSUE INJURY; TISSUE REPAIR;

HUMANS; PLATELET-RICH PLASMA; REGENERATIVE MEDICINE; WOUND HEALING;

EID: 84884215080     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.13.59     Document Type: Review

References (90)

1. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: From pure platelet-rich plasma (.P-PRP) to leucocyte- and platelet-rich fibrin (.L-PRF). Trends Biotechnol. 27(3), 158-167 (.2009
2. Bielecki T, Dohan Ehrenfest DM, Everts PA, Wiczkowski A. The role of leukocytes from L-PRP/L-PRF in wound healing and immune defense: New perspectives. Curr. Pharm. Biotechnol. 13(7), 1153-1162 (.2012
3. Andia I, Sanchez M, Maffulli N. Tendon healing and platelet-rich plasma therapies. Expert Opin. Biol. Ther. 10(10), 1415-1426 (.2010
4. Everts PA, Devilee RJ, Brown Mahoney C et al. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta Anaesthesiol. Scand. 50(5), 593-599 (.2006
5. Zhou SF, Estrera AL, Miller 3rd CC et al. Analysis of autologous platelet-rich plasma during ascending and transverse aortic arch surgery. Ann. Thorac. Surg. 95(5), 1525-1530 (.2012
6. Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 24(3), 483-488 (.2001
7. Anitua E, Aguirre JJ, Algorta J et al. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J. Biomed. Mater. Res. B Appl. Biomater. 84(2), 415-421 (.2008
8. Gardner MJ, Demetrakopoulos D, Klepchick PR, Mooar PA. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion. Int. Orthop. 31(3), 309-313 (.2007
9. Bloomfield MR, Klika AK, Molloy RM, Froimson MI, Krebs VE, Barsoum WK. Prospective randomized evaluation of a collagen/thrombin and autologous platelet hemostatic agent during total knee arthroplasty. J. Arthroplasty 27(5), 695-702 (.2012
10. Bernasek TL, Burris RB, Fujii H, Levering MF, Polikandriotis JA, Patterson JJ. Effect on blood loss and cost-effectiveness of pain cocktails, platelet-rich plasma, or fibrin sealant after total knee arthroplasty. J. Arthroplasty 27(8), 1448-1451 (.2012
11. Dilorio TM, Burkholder JD, Good RP, Parvizi J, Sharkey PF. Platelet-rich plasma does not reduce blood loss or pain or improve range of motion after TKA. Clin. Orthop. Relat. Res. 470(1), 138-143 (.2012
12. Nurden P, Youlouz-Marfak I, Siberchicot F et al. Use of autologous platelet-rich clots for the prevention of local injury bleeding in patients with severe inherited mucocutaneous bleeding disorders. Haemophilia 17(4), 620-624 (.2011
13. Flad HD, Brandt E. Platelet-derived chemokines: Pathophysiology and therapeutic aspects. Cell Mol. Life Sci. 67, 2363-2386 (.2010
14. Vandercapellen J, Van Damme J, Struyf S. The role of CXC chemokines platelet factor-4 (.CXCL4/PF4) and its variant (.CXCLaL1/ PF-avar) in inflammation, angiogenesis and cancer. Cytokine Growth Factors Rev. 22(1), 1-18 (.2011
15. Gleissner CA, Shaked I, Little KM, Ley K. CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J. Immunol. 184, 4810-4818 (.2010
16. van Buul GM, Koevoet W, Kops N et al. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am. J. Sports Med. 39(11), 2362-2370 (.2011
17. Bendinelli P, Matteucci E, Dogliotti G et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: Mechanisms of NF-kappa B inhibition via HGF. J. Cell Physiol. 225, 757-766 (.2010
18. Lippross S, Moeller B, Haas H et al. Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint. Arthritis Rheum. 63(11), 3344-3353 (.2011
19. Andia I, Sánchez M, Maffulli N. Joint pathology and platelet-rich plasma therapies. Expert Opin. Biol. Ther. 12(1), 7-22 (.2012
20. Vang SN, Brady CP, Christensen KA et al. Autologous platelet gel in coronary artery bypass grafting: Effects on surgical wound healing. J. Extra Corpor. Technol. 39(1), 31-38 (.2007
21. Vick VL, Holds JB, Hartstein ME, Rich RM, Davidson BR. Use of autologous platelet concentrate in blepharoplasty surgery. Ophthal. Plast. Reconstr. Surg. 22(2), 102-104 (.2006
22. Sidman JD, Lander TA, Finkelstein M. Platelet-rich plasma for pediatric tonsillectomy patients. Laryngoscope 118(10), 1765-1767 (.2008
23. Na JI, Choi JW, Choi HR et al. Rapid healing and reduced erythema after ablative fractional carbon dioxide laser resurfacing combined with the application of autologous platelet-rich plasma. Dermatol. Surg. 37(4), 463-468 (.2011
24. López-Plandolit S, Morales MC, Freire V, Etxebarría J, Durán JA. Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects. Cornea 29(8), 843-848 (.2010
25. Sheth U, Simunovic N, Klein G et al. Efficacy of autologous platelet-rich plasma use for orthopaedic indications: A meta-analysis. J. Bone Joint. Surg. Am. 94(4), 298-307 (.2012
26. Everts PA, Devilee RJ, Brown Mahoney C et al. Exogenous application of platelet-leukocyte gel during open subacromial decompression contributes to improved patient outcome. A prospective randomized double-blind study. Eur. Surg. Res. 40, 203-210 (.2008
27. Randelli P, Arrigoni P, Ragone V, Aliprandi A, Cabitza P. Platelet rich plasma in arthroscopic rotator cuff repair: A prospective RCT study, 2-year follow-up. J. Shoulder Elbow Surg. 20, 518-528 (.2011
28. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: Platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am. J. Sports Med. 38, 255-262 (.2010
29. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am. J. Sports Med. 34, 1774-1778 (.2006
30. Nin JR, Gasque GM, Azcárate AV, Beola JD, Gonzalez MH Has platelet-rich plasma any role in anterior cruciate ligament allograft healing? Arthroscopy 25, 1206-1213 (.2009
31. Cervellin M, de Girolamo L, Bait C, Denti M, Volpi P. Autologous platelet-rich plasma gel to reduce donor-site morbidity after patellar tendon graft harvesting for anterior cruciate ligament reconstruction: A randomized, controlled clinical study. Knee Surg. Sports Traumatol. Arthrosc. 20(1), 114-120 (.2012
32. Filardo G, Kon E, Della Villa S, Vincentelli F, Fornasari PM, Marcacci M. Use of platelet-rich plasma for the treatment of refractory jumper's knee. Int. Orthop. 34, 909-915 (.2010
33. D'Elia CO, de Rezenda MU, Bitar AC et al. Comparison between platelet-rich plasma and autologous iliac grafts for tibial osteotomy. Cartilage 1, 320-327 (.2010
34. Jenis LG, Banco RJ, Kwon B. A prospective study of autologous growth factors (.AGF) in lumbar interbody fusion. Spine J. 6, 14-20 (.2006
35. Filardo G, Kon E, Pereira Ruiz MT et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: Single- versus double-spinning approach. Knee Surg. Sports Traumatol. Arthrosc. 20(10), 2082-2091 (.2012
36. Sánchez M, Fiz N, Azofra J et al. A randomized clinical trial evaluating plasma rich in growth factors (.PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy 28(8), 1070-1078 (.2012
37. Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M. Platelet rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am. J. Sports Med. 40(3), 534-541 (.2012
38. Kon E, Mandelbaum B, Buda R et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: From early degeneration to osteoarthritis. Arthroscopy 27(11), 1490-1501 (.2011
39. Spakòva T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am. J. Phys. Med. Rehabil. 91(4), 1-7 (.2012
40. Sampson S, Reed M, Silvers H et al. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: A pilot study. Am. J. Phys. Med. Rehabil. 89(12), 961-969 (.2010
41. Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front. Biosci. 13, 3532-3548 (.2008
42. Andia I, Abate M. Platelet rich plasma injections for tendinopathy and osteoarthritis. Int. J. Clin. Rheumatol. 7(4), 397-412 (.2012
43. Peterson JE, Zurakowski D, Italiano JE Jr et al. Normal ranges of angiogenesis regulatory proteins in human platelets. Am. J. Hematol. 85(7), 487-493 (.2010
44. Li XH, Zhou X, Zeng S et al. Effects of intramyocardial injection of platelet-rich plasma on the healing process after myocardial infarction. Coron. Artery Dis. 19(5), 363-370 (.2008
45. Bir SC, Esaki J, Marui A et al. Angiogenic properties of sustained release platelet-rich plasma: Characterization in vitro and in the ischemic hind limb of the mouse. J. Vasc. Surg. 50(4), 870-879 (.2009
46. Bosch G, Moleman M, Barneveld A, van Weeren PR, van Schie HT. The effect of platelet-rich plasma on the neovascularization of surgically created equine superficial digital flexor tendon lesions. Scand. J. Med. Sci. Sports 21(4), 554-561 (.2011
47. Gomez-Caro A, Ausin P, Boada M. Platelet rich plasma improves the healing process after airway anastomosis. Interact. Cardiovasc. Thorac. Surg. 13(6), 552-556 (.2011
48. Li W, Enomoto M, Ukegawa M et al. Subcutaneous injections of platelet-rich plasma into skin flaps modúlate proangiogenic gene expression and improve survival rates. Plast. Reconstr. Surg. 129(4), 858-866 (.2012
49. Findikcioglu F, Findikcioglu K, Yavuzer R, Lortlar N, Atabay K. Effect of preoperative subcutaneous platelet-rich plasma and fibrin glue application on skin flap survival. Aesthetic Plast. Surg. 36(5), 1246-1253 (.2012
50. Saad Setta H, Elshahat A, Elsherbiny K, Massoud K, Safe I. Platelet-rich plasma versus platelet-poor plasma in the management of chronic diabetic foot ulcers: A comparative study. Int. Wound J. 8(3), 307-312 (.2011
51. Driver VR, Hanft J, Fylling CP, Beriou JM; Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage. 52(6), 68-70 (.2006
52. Frykberg RG, Driver VR, Carman D et al. Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: A prospective case series. Ostomy Wound Manage. 56(6), 36-44 (.2010
53. de Leon JM, Driver VR, Fylling CP et al. The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel. Adv. Skin Wound Care 24(8), 357-368 (.2011
54. Carter MJ, Fylling CP, Li WW et al. Analysis of run-in and treatment data in a wound outcomes registry: Clinical impact of topical platelet-rich plasma gel on healing trajectory. Int. Wound J. 8(6), 638-650 (.2011
55. Sakata J, Sasaki S, Handa K et al. A retrospective, longitudinal study to evaluate healing lower extremity wounds in patients with diabetes mellitus and ischemia using standard protocols of care and platelet-rich plasma gel in a Japanese wound care program. Ostomy Wound Manage. 58(4), 36-49 (.2012
56. Dougherty EJ. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers. Adv. Skin Wound Care 21(12), 568-575 (.2008
57. Dionyssiou D, Demiri E, Foroglou P et al. The effectiveness of intralesional injection of platelet-rich plasma in accelerating the healing of chronic ulcers. An experimental and clinical study. Int. Wound J. 10(4), 397-406 (.2013
58. Kakudo N, Kushida S, Minakata T, Suzuki K, Kusumoto K. Platelet-rich plasma promotes epithelialization and angiogenesis in a splitthickness skin graft donor site. Med. Mol. Morphol. 44(4), 233-235 (.2011
59. Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I et al. Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst. Rev. 10, CD006899 (.2012
60. Guadilla J, Fiz N, Andia I, Sánchez M. Arthroscopic management and platelet-rich plasma therapy for avascular necrosis of the hip. Knee Surg. Sports Traumatol. Arthrosc. 20(2), 393-398 (.2012
61. Ibrahim V, Dowling H. Platelet-rich plasma as a nonsurgical treatment option for osteonecrosis. PM R 4(12), 1015-1019 (.2012
62. Bocanegra-Pérez S, Vicente-Barrero M, Knezevic M et al. Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw. Int. J. Oral Maxillofac. Surg. 41(11), 1410-1415 (.2012
63. Mozzati M, Gallesio G, Arata V, Pol R, Scoletta M. Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: A report of 32 cases. Oral Oncol. 48(5), 469-474 (.2012
64. Coviello V, Peluso F, Dehkhargani SZ et al. Platelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients. J. Biol. Regul. Homeost. Agents 26(1), 151-155 (.2012
65. Curi MM, Cossolin GS, Koga DH et al. Bisphosphonate-related osteonecrosis of the jaws - an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma. J. Oral Maxillofac. Surg. 69(9), 2465-2472 (.2011
66. Martins MA, Martins MD, Lascala CA et al. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: A preliminary study. Oral Oncol. 48(1), 79-84 (.2012
67. Kim KM, Shin YT, Kim HK. Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis. Jpn. J. Ophthalmol. 56(6), 544-550 (.2012
68. Alio JL, Colecha JR, Pastor S, Rodriguez A, Artola A. Symptomatic dry eye treatment with autologous platelet-rich plasma. Ophthalmic Res. 39(3), 124-129 (.2007
69. López-Plandolit S, Morales MC, Freire V, Grau AE, Durán JA. Efficacy of plasma rich in growth factors for the treatment of dry eye. Cornea 30(12), 1312-1317 (.2011
70. Hayes AJ, Ralphs Jr. The response of foetal annulus fibrosus cells to growth factors: Modulation of matrix synthesis by TGF-b1 and IGF-1. Histochem. Cell Biol. 136(2), 163-175 (.2011
71. Sahin H, Wasmuth HE. Chemokines in tissue fibrosis. Biochim. Biophys. Acta 1832(7), 1041-1048 (.2013
72. Vavken P, Sadoghi P, Murray MM. The effect of platelet concentrates on graft maturation and graft-bone interface healing in anterior cruciate ligament reconstruction in human patients: A systematic review of controlled trials. Arthroscopy 27(11), 1573-1583 (.2011
73. Sánchez M, Anitua E, Andia I. Poor standardization in platelet-rich therapies hampers advancement. Arthroscopy 26(6), 725-726 (.2010
74. de Almeida AM, Demange MK, Sobrado MF, Rodrigues MB, Pedrinelli A, Hernandez AJ. Patellar tendon healing with platelet-rich plasma: A prospective randomized controlled trial. Am. J. Sports Med. 40(6), 1282-1288 (.2012
75. Chahal J, Van Thiel GS, Mall N et al. The role of platelet-rich plasma in arthroscopic rotator cuff repair: A systematic review with quantitative synthesis. Arthroscopy 28(11), 1718-1727 (.2012
76. Volpi P, Quaglia A, Schoenhuber H et al. Growth factors in the management of sport-induced tendinopathies: Results after months from treatment. A pilot study. J. Sports Med. Phys. Fitness 50(4), 494-500 (.2010
77. Ferrero G, Fabbro E, Orlandi D et al. Ultrasound-guided injection of platelet-rich plasma in chronic Achilles tendinopathy. J. Ultrasound 15(4), 260-266 (.2012
78. Monto RR. Platelet rich plasma treatment for chronic Achilles tendinosis. Foot Ankle Int. 33(5), 379-385 (.2012
79. de Jonge S, de Vos RJ, Weir A et al. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: A double-blind randomized placebo-controlled trial. Am. J. Sports Med. 39(8), 1623-1629 (.2011
80. Owens RF Jr, Ginnetti J, Conti SF, Latona C. Clinical and magnetic resonance imaging outcomes following platelet rich plasma injection for chronic midsubstance Achilles tendinopathy. Foot Ankle Int. 32(11), 1032-1039 (.2011
81. Gentile P, Di Pasquali C, Bocchini I et al. Breast reconstruction with autologous fat graft mixed with platelet-rich plasma. Surg. Innov. 20(4), 370-376 (.2012
82. Sommeling CE, Heyneman A, Hoeksema H, Verbelen J, Stillaert FB, Monstrey S. The use of platelet-rich plasma in plastic surgery: A systematic review. J. Plast. Reconstr. Aesthet. Surg. 66(3), 301-311 (.2012
83. Kazakos K, Lyras DN, Verettas D, Tilkeridis K, Tryfonidis M. The use of autologous PRP gel as an aid in the management of acute trauma wounds. Injury 40(8), 801-805 (.2009
84. Cervelli V, Scioli MG, Gentile P et al. Platelet-rich plasma greatly potentiates insulin-induced adipogenic differentiation of human adipose-derived stem cells through a serine/ threonine kinase Akt-dependent mechanism and promotes clinical fat graft maintenance. Stem Cells Transl. Med. 1(3), 206-220 (.2012
85. Salgarello M, Visconti G, Rusciani A. Breast fat grafting with platelet-rich plasma: A comparative clinical study and current state of the art. Plast. Reconstr. Surg. 127(6), 2176-2185 (.2011
86. Sclafani AP, McCormick SA. Induction of dermal collagenesis, angiogenesis, and adipogenesis in human skin by injection of platelet-rich fibrin matrix. Arch. Facial Plast. Surg. 14(2), 132-136 (.2012
87. Takikawa M, Nakamura S, Ishirara M et al. Enhanced effect of platelet-rich plasma containing a new carrier on hair growth. Dermatol. Surg. 37(12), 1721-1729 (.2011
88. Li ZJ, Choi HI, Choi DK et al. Autologous platelet-rich plasma: A potential therapeutic tool for promoting hair growth. Dermatol. Surg. 38(7 Pt 1), 1040-1046 (.2012
89. Dragoo JL, Braun HJ, Durham JL et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am. J. Sports Med. 40(6), 1274-1281 (.2012
90. Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am. J. Sports Med. 39(10), 2135-2140 (.2011